SCHEMBL1586598

SCHEMBL1586598

NCC1(NCCc2ccccc2)CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
CYP2C9 P11712 2/20 0.42
TSHR P16473 2/20 0.42
CYP2C19 P33261 2/20 0.42
LMNA P02545 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
KDM1A O60341 1/20 0.42
CYP1A2 P05177 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
CYP2C8 P10632 1/20 0.42
IDO1 P14902 1/20 0.42
NFKB1 P19838 1/20 0.42
MAOA P21397 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1587373 0.91 SIGMAR1 (0.43) ALDH1A1CYP2C9TSHRCYP2C19MAOA
SCHEMBL1586715 0.84 TACR1 (0.42) ALDH1A1CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL27887682 0.72 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2CYP2C9TSHRCYP2C19
Formic Acid SCHEMBL27531693 0.70 TACR1 (0.42) CYP2C19CYP3A4TACR1MEN1KMT2A
Phenethylamine SCHEMBL11627755 0.69 HTR2A (0.76) SMN1; SMN2CYP2C19CYP2D6CYP1A2MAOA
SCHEMBL1586350 0.69 CYP2D6 (0.44) ALDH1A1SMN1; SMN2CYP2C9TSHRCYP2C19
SCHEMBL6623954 0.69 EPHX1 (0.49) CYP2C19CYP3A4TACR1EPHX1
SCHEMBL23083579 0.68 MAOA (0.47) ALDH1A1CYP2C9TSHRCYP2C19CYP2D6
SCHEMBL20787990 0.68 TACR1 (0.45) ALDH1A1CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL9954933 0.68 DPP4 (0.44) TSHRCYP3A4IDO1MAOASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2490687-A1 COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES Vertex Pharmaceuticals Incorporated (US) 2012-08-29 EP disclosed
WO-2011050325-A1 COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-28 WO disclosed
EP-2231280-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2010-09-29 EP disclosed
WO-2009074575-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-06-18 WO disclosed